MANDAS, ANTONELLA
 Distribuzione geografica
Continente #
EU - Europa 152.900
NA - Nord America 8.270
AS - Asia 3.959
SA - Sud America 476
AF - Africa 99
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 2
Totale 165.727
Nazione #
IT - Italia 150.247
US - Stati Uniti d'America 8.138
SG - Singapore 1.522
CN - Cina 1.355
UA - Ucraina 646
SE - Svezia 481
DE - Germania 360
BR - Brasile 359
VN - Vietnam 347
GB - Regno Unito 285
FI - Finlandia 284
FR - Francia 234
HK - Hong Kong 143
IN - India 124
NL - Olanda 98
BD - Bangladesh 97
KR - Corea 82
CA - Canada 69
RU - Federazione Russa 54
AR - Argentina 38
JP - Giappone 37
PL - Polonia 36
EC - Ecuador 30
IQ - Iraq 30
TR - Turchia 25
ZA - Sudafrica 25
AT - Austria 24
ES - Italia 24
IR - Iran 23
MX - Messico 22
BE - Belgio 20
IE - Irlanda 20
PH - Filippine 18
PK - Pakistan 17
AU - Australia 16
ID - Indonesia 16
MA - Marocco 15
SA - Arabia Saudita 15
MY - Malesia 14
NG - Nigeria 14
UZ - Uzbekistan 14
CH - Svizzera 13
EG - Egitto 13
JM - Giamaica 13
TH - Thailandia 13
CO - Colombia 12
AL - Albania 10
GR - Grecia 9
OM - Oman 9
VE - Venezuela 9
LT - Lituania 8
CL - Cile 7
JO - Giordania 7
AE - Emirati Arabi Uniti 6
BO - Bolivia 6
DK - Danimarca 6
DO - Repubblica Dominicana 6
NP - Nepal 6
TN - Tunisia 6
TW - Taiwan 6
ET - Etiopia 5
LB - Libano 5
NZ - Nuova Zelanda 5
PE - Perù 5
PY - Paraguay 5
RO - Romania 5
UY - Uruguay 5
AZ - Azerbaigian 4
BH - Bahrain 4
CY - Cipro 4
HN - Honduras 4
HR - Croazia 4
LV - Lettonia 4
MU - Mauritius 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
DZ - Algeria 3
KE - Kenya 3
KG - Kirghizistan 3
LU - Lussemburgo 3
LY - Libia 3
MD - Moldavia 3
PT - Portogallo 3
RS - Serbia 3
SN - Senegal 3
BG - Bulgaria 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
GT - Guatemala 2
HU - Ungheria 2
IL - Israele 2
IS - Islanda 2
NI - Nicaragua 2
PA - Panama 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
AM - Armenia 1
BB - Barbados 1
Totale 165.709
Città #
Cagliari 143.883
Uta 3.872
Singapore 837
Ashburn 700
Chandler 586
Fairfield 557
San Jose 529
Woodbridge 511
Ann Arbor 477
Boardman 454
Dallas 434
Jacksonville 349
Houston 334
Nyköping 290
Wilmington 283
Seattle 242
Beijing 205
Cambridge 200
Milan 180
Rome 180
Council Bluffs 178
Helsinki 176
Hefei 171
Los Angeles 138
Hong Kong 131
Dearborn 127
Santa Clara 121
Nanjing 105
Boston 101
Ho Chi Minh City 101
Lauterbourg 93
New York 88
Shanghai 80
Seoul 69
Hanoi 68
Sassari 63
Verona 61
Naples 60
Buffalo 55
Dong Ket 46
São Paulo 45
Turin 45
The Dalles 44
Bari 40
Shenyang 40
Frankfurt am Main 39
Hebei 34
San Diego 33
Nanchang 32
Jiaxing 31
Chicago 29
Munich 29
Redwood City 29
Changsha 28
London 27
Pune 27
Zhengzhou 27
Tianjin 26
Tokyo 26
Guangzhou 25
Redondo Beach 25
Washington 25
Atlanta 23
Toronto 23
Brooklyn 22
Orem 22
Warsaw 22
Genoa 19
Phoenix 19
Brussels 18
Catania 18
Da Nang 18
Jinan 18
Nuremberg 18
Orange 18
Rio de Janeiro 18
Amsterdam 17
Baghdad 17
Chennai 17
Bay Shore 16
Bologna 16
Denver 16
Montreal 16
Mountain View 16
Auburn Hills 15
Mumbai 15
Norwalk 15
Florence 14
Hangzhou 13
Porto Torres 13
Wuhan 13
Brescia 12
Guayaquil 12
Haiphong 12
Quito 12
Dublin 11
Gravina In Puglia 11
Palermo 11
Stockholm 11
Vienna 11
Totale 158.449
Nome #
null 3.998
Cognitive decline and depressive symptoms in late-life are associated with statin use: evidence from a population-based study of Sardinian old people living in their own home 3.397
Glucose-6-phosphate-dehydrogenase deficiency as a risk factor for pterygium 3.201
null 3.087
A Determination of Neutral Lipid and Cluster Formation for Screening Neurocognitive Impairment in Human Immunodeficiency Virus Patients 3.031
null 2.985
null 2.897
Abnormal lipid accumulation and cluster formation of naive peripheral blood mononuclear cells: a useful tool for early detection of central nervous system damage in elderly 2.881
Resting-state functional connectivity MRI analysis in Human Immunodeficiency Virus and Hepatitis C Virus co-infected subjects. A pilot study 2.822
The venous thromboembolic risk and the clot wave analysis: a useful relationship? 2.772
ACAT-1, Cav-1 and PrP expression in scrapie susceptible and resistant sheep 2.671
Networks in the brain: from neurovascular coupling of the BOLD effect to brain functional architecture 2.670
The natural course of chronic HBsAg positive hepatitis with serum HBV-DNA and anti-HBe in Sardinia 2.595
Accumulation of neutral lipids in peripheral blood mononuclear cells as a distinctive trait of Alzheimer patients and asymptomatic subjects at risk of disease 2.500
null 2.446
Oxidative Imbalance in HIV-1 Infected Patients Treated with Antiretroviral Therapy 2.443
Lipid derangement and prion misfolding in prion infected mouse neuroblastoma cells lines and in brains and skin fibroblasts from scrapie-susceptible sheep 2.295
null 2.280
null 2.267
Thalassemia intermedia is associated with a proatherogenic biochemical phenotype 2.156
Systemic alteration of Cholesterol Homeostasis in experimental and natural scrapie 2.121
null 2.100
Physical Performance and Falling Risk Are Associated with Five-Year Mortality in Older Adults: An Observational Cohort Study 2.077
null 2.030
null 1.971
Epidemiology of HDV infection in Sardinia, an island with a high endemicity for HBV: A multicenter study 1.913
null 1.848
Studio ecografico dei linfonodi del legamento epatoduodenale in pazienti con epatite cronica virale 1.806
New method for early detection of CNS damage in elderly subjects: abnormal lipid accumulation and cluster formation in naive PBMCs 1.794
null 1.769
Epidemiology of infection with HIV-1 in Sardinia: a multicentre prospective study 1.711
null 1.660
Molecular epidemiology of intrafamilial transmission of hepatitis C virus: A controlled study 1.658
Multidimensional geriatric assessment in elderly HIV patients 1.631
null 1.601
Immunological aspects in anti-HIV seronegative drug addicts. Correlation with the duration of heroin addiction and other viral infections 1.572
null 1.527
RBANS: un valido strumento di valutazione cognitiva in soggetti HIV-infetti in cART = RBANS: a valid tool for cognitive assessment of HIV-infected people on cART 1.493
The Role of Peripheral Cells in Neurocognitive Disorders Detection 1.459
null 1.450
[Immunological aspects in anti-HIV seronegative drug addicts. Correlation with the duration of heroin addiction and other viral infections]. FT Aspetti immunologici nei tossicodipendenti anti-HIV sieronegativi. Correlazione con la durata di assunzione dell'eroina e con altre infezioni virali. 1.373
Prevalenza e caratteristiche cliniche dell’infezione delta in emodializzati portatori cronici di HBsAg 1.364
null 1.355
The hidden treasure of 24-hours ambulatory blood pressure monitoring—Assessing BP variability 1.332
null 1.320
The Repeatable Battery for the Assessment of Neuropsychological Status as a screening strategy for HIV-Associated Neurocognitive Disorders 1.304
Prevalence and clinical significance of serum HBV-DNA in the course of anti-HBe positive chronic hepatitis B in Sardinia 1.299
Correlation between depressive symptoms and cognitive impairment and use of hmg-coa reductase inhibitors in a group of elderly subjects evaluated in their own homes 1.270
Cholesterol esterification during differentiation of mouse erythroleukemia (Friend) cells 1.244
A prognostic model for estimating the time to virologic failure in HIV-1 infected patients undergoing a new combination antiretroviral therapy regimen 1.220
Epidemiologia dell’infezione da HIV a Cagliari: studio multicentrico 1.197
Prevalenza e significato clinico dell’HBV-DNA nel siero dei portatori cronici di HBsAg/anti-HBe positivi in Sardegna 1.173
null 1.158
Aspetti immunologici nei tossicodipendenti anti-HIV sieronegativi. Correlazione con la durata di assunzione dell’eroina e con altre infezioni virali 1.139
null 1.112
Epidemiologic patterns of infection with HIV in Sardinia. A multicentre study 1.107
Emergency department: risk stratification in the elderly 1.008
null 1.003
Cognitive Impairment and Age-Related Vision Disorders: Their Possible Relationship and the Evaluation of the Use of Aspirin and Statins in a 65 Years-and-Over Sardinian Population 993
High prevalence of thyroid dysfunction in adult patients with beta-thalassemia major submitted to amiodarone treatment 962
Valutazione multidimensionale geriatrica: confronto tra un gruppo di anziani valutati ambulatorialmente e un gruppo di anziani valutati a domicilio 924
null 919
null 915
null 914
Comprehensive Geriatric Assessment: Application and correlations in a real-life cross-sectional study 875
Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016 854
null 803
null 742
Mini-Mental State Examination: Optimal Cut-Off Levels for Mild and Severe Cognitive Impairment 729
null 706
Pharmacologic cholesterol homeostasis affects prion generation in a synergistic manner 686
null 683
Long-term effect of lymphoblastoid interferon therapy of anti-HBe and HBV-DNA positive chronic hepatitis B 681
How to evaluate Quality of Life 678
In vitro synergistic anti-prion effect of cholesterol ester modulators in combination with chlorpromazine and quinacrine 631
Association between Depressive Mood, Antidepressant Therapy and Neuropsychological Performances: Results from a Cross-Sectional Study on Elderly Patients 630
Cognitive assessment with neurocognitive screening tools 617
Favourable response to lymphoblastoid interferon of anti-HBe positive chronic Hepatitis type B 604
"Delirium Day": A nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 596
Valutazione multidimensionale geriatrica di un gruppo di anziani ultraottantacinquenni studiati nel proprio domicilio 595
Diabetes mellitus, malnutrition, and sarcopenia: The bond is not explained by bioelectrical impedance analysis in older adults 588
MMSE e MODA due metodiche a confronto nello screening del deficit cognitivo nel soggetto anziano valutato sul territorio: dati preliminari 585
Treatment of chronic delta hepatitis with higt and low doses of interferon alpha-2a. A randomizzed controlled trial 571
Nutritional Status and Potentially Inappropriate Medications in Elderly: Real-World Experience 569
Fragilità: confronto tra un gruppo di anziani valutati nel proprio domicilio e un gruppo di anziani valutati ambulatorialmente 546
Valutazione multidimensionale di una popolazione di anziani fragili: correlazione del PPT con le altre aree dimensionali 543
Valutazione dello stato nutrizionale di una popolazione di soggetti anziani: correlazione del MNA con altre aree dimensionali 533
Cholesterol esterification as a mediator of proliferation of vascular smooth muscle cells and peripheral blood mononuclear cells during atherogenesis 531
STOPP/START antiaggregation and anticoagulation alerts in atrial fibrillation 529
null 528
Variazioni della massa ossea nei pazienti con b Talassemia major in trattamento con calcio, Vitamina D e bisfosfonati. 528
Cholesterol homeostasis: a key to prevent or slow down neurodegeneration 524
The response to lymphoblastoid interferon of anti-HBe and HBV-DNA positive patients with chronic hepatitis B 523
L'Interferone nella terapia dell’epatite cronica delta 520
Randomized controlled trial of high and low doses of interferon (IFN) alpha-2a (Roferon-A) in chronic HDV hepatitis 517
Valutazione multidimensionale: monitoraggio della fragilità in un gruppo di soggetti ultrasessantacinquenni 515
Anemia in Elderly Patients-The Impact of Hemoglobin Cut-Off Levels on Geriatric Domains 513
Efficacia e tollerabilità della terapia antiretrovirale altamente attiva (HAART) negli over 60: descrizione di 3 casi clinici 513
Orthogeriatric Assessment of the Elderly Patient with Fragility Hip Fracture: Preliminary Results of a Prospective Study 509
Anti-HBe and HBV-DNA positive chronic hepatiis B: response to interferon therapy 502
Totale 139.987
Categoria #
all - tutte 211.216
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 211.216


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.449 0 0 0 0 0 0 0 0 0 0 0 1.449
2021/20228.463 745 676 614 438 596 555 637 525 645 869 969 1.194
2022/202312.819 1.364 1.702 1.638 1.028 1.067 1.234 560 827 786 891 1.019 703
2023/202415.146 614 615 509 874 1.438 2.704 2.777 994 674 1.145 1.438 1.364
2024/202531.414 6.890 8.509 4.281 3.782 2.367 1.737 2.554 169 324 211 277 313
2025/20268.652 570 479 880 457 617 533 1.112 935 919 887 612 651
Totale 166.192